A. Tienhaara et al., SERUM IMMUNOREACTIVE INTERLEUKIN-6 AND C-REACTIVE PROTEIN-LEVELS IN PATIENTS WITH MULTIPLE-MYELOMA AT DIAGNOSIS, British Journal of Haematology, 86(2), 1994, pp. 391-393
Serum bioactive but not immunoreactive interleukin-6 (IL-6), and serum
C-reactive protein (CRP), have been reported to be of prognostic sign
ificance in multiple myeloma (MM). We measured serum immunoreactive IL
-6 by a sensitive enzyme-linked immunosorbent assay in 30 MM patients
at diagnosis. In 30% of the patients serum immunoreactive IL-6 exceede
d the upper reference limit. The concentrations of CRP and IL-6 showed
a linear association. Logarithmically transformed IL-6, CRP and Pz-mi
croglobulin were significant variables by univariate survival analysis
; by multivariate analysis CRP was a slightly stronger prognostic fact
or than IL-6 and the only one of independent prognostic significance.